Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.76) by 17.11 percent. This is a 3250 percent decrease over earnings of $0.02 per share from the same period last year.
AgriFORCE Selects Premier Performance Marketing Agency New Engen To Support Upcoming Launch Of Awakened Grains
AgriFORCE (NASDAQ:AGRI, AGRIW)))), an intellectual property (IP)-focused AgTech company dedicated to advancing sustainable cultivation and crop processing across multiple platforms, today announced that it
